Will the U.S. Supreme Court be the Arbiter of Drug Safety? (Guest: Rik Mehta)

How is it that Mifepristone was approved in the first place?  The drug has high risk implications and because of that was authorized under a specific protocol that the Biden administration is now trying to change after the Dobb’s decision last year that reversed Roe v. Wade.  Guest Rik Mehta comes onto the podcast to discuss the legal nature of it all.